PatientsVille.com Logo

HYPOTENSION and Ritalin

PatientsVille

HYPOTENSION Symptoms and Causes

You've probably heard that high blood pressure is a problem. Sometimes blood pressure that is too low can also cause problems.

Blood pressure is the force of your blood pushing against the walls of your arteries. Each time your heart beats, it pumps out blood into the arteries. Your blood pressure is highest when your heart beats, pumping the blood. This is called systolic pressure. When your heart is at rest, between beats, your blood pressure falls. This is the diastolic pressure. Your blood pressure reading uses these two numbers. Usually they're written one above or before the other, such as 120/80. If your blood pressure reading is 90/60 or lower, you have low blood pressure.

Some people have low blood pressure all the time. They have no symptoms and their low readings are normal for them. In other people, blood pressure drops below normal because of a medical condition or certain medicines. Some people may have symptoms of low blood pressure when standing up too quickly. Low blood pressure is a problem only if it causes dizziness, fainting or in extreme cases, shock.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for HYPOTENSION

➢ HYPOTENSION treatment research studies

➢ Ritalin clinical trials, surveys and public health registries

Find Drug Side Effect reports



Ritalin Side Effects

Depression (131)
Aggression (111)
Agitation (101)
Headache (94)
Anxiety (88)
Abnormal Behaviour (80)
Disturbance In Attention (79)
Feeling Abnormal (77)
Nausea (76)
Insomnia (66)
Decreased Appetite (60)
Dizziness (56)
Suicidal Ideation (53)
Dyspnoea (51)
Hyperhidrosis (50)
Fatigue (48)
Tremor (47)
Hallucination (46)
Irritability (46)
Weight Decreased (46)
Somnolence (46)
Hypertension (45)
Confusional State (45)
Vomiting (44)
Tachycardia (44)
Malaise (43)
Suicide Attempt (41)
Nervousness (40)
Convulsion (39)
Hallucination, Auditory (39)
Attention Deficit/hyperactivity Disorder (38)
Bipolar Disorder (38)
Crying (37)
Heart Rate Increased (36)
Depressed Mood (36)
Memory Impairment (33)
Chest Pain (33)
Psychomotor Hyperactivity (33)
Pyrexia (33)
Fall (32)
Blood Pressure Increased (32)
Anorexia (32)
Loss Of Consciousness (31)
Psychotic Disorder (31)
Weight Increased (31)
Palpitations (30)
Abdominal Pain Upper (30)
Asthenia (29)
Blood Creatine Phosphokinase Increased (25)
Apathy (25)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Glucophage causing to me severe hypotension - can reach 80\50 .. and diarrhea with abdominal cramps ..

I have 2 years with this ventricular extrasystoles, doctor said is panic attack, i am 42 years old, my hormones are fine, now i have hypotension and my heart rate is 46-52, the doctor send me to the cardiologyst. What elsecan i do

My Father who is 78 years of age was giveN 2ML ABOCAIN THAT RESULTED IN 1) Hypotension 2) Apnea 3) Infarct in bothe occipetal Lobes, Cereblum He is now a living dead. Nadeem

Today 16 Feb.2010 a 33 yr old man pt was diagnosed to has renal colic and liometacen amp. was given directly iv. with susequent anaphylactic shock hypotension, bradycardia . vaso vagal attack. the pt admitted icu and now after 4 hours he is

HYPOTENSION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia
Conditions: Obstetric Anesthesia;   Spinal Anesthesia;   Hypotension;   Fluid Therapy;   Cesarean Section
Intervention: Drug: Hydroxyethylstarch 130/0.4
Outcome Measures: Volume of HES which will prevent Hypotension if 50 % of the subjects.;   Incidence of Hypotension episodes;   Incidence of hypertensive episodes;   cardiac output;   Apgar score;   umbilical artery pH;   additional vasopressors administered
2 Not yet recruiting An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty
Condition: Orthostatic Hypotension
Interventions: Drug: Midodrine;   Other: Intravenous fluid bolus
Outcome Measures: Change in Orthostatic Hypotension Questionnaire score;   Length of stay;   Orthostatic Hypotension/dizziness;   Cardiac parameters (BP, AI, CO, HR, SVV, SVR);   Number of attempts at physical therapy;   Successful physical therapy sessions and milestones;   Resolution of orthostatic Hypotension
3 Recruiting Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
Conditions: Parkinsonian Patients;   Post-prandial Sleepiness;   Orthostatic Hypotension
Interventions: Other: V1: HGPO + meal and V2: placebo + meal;   Other: V1: placebo 75mg + meal and V2: HGPO 75mg + meal
Outcome Measures: Rate of patients presenting a "sleep onset";   rate of patients without arterial Hypotension nor a sleep episode within 120 minutes after oral solution administration ;;   rate of patients that show a sleep episode but without arterial Hypotension within 120 minutes after oral solution administration ;;   rate of patients that show arterial Hypotension within 120 minutes after oral solution administration but not a sleep episode;;   Occurrence of arterial Hypotension and a sleep episode within 120 minutes following a standardized meal;   Changes in intestine-pancreatic neuropeptides including incretins (GLP-1 - GIP) following an oral glucose load, placebo fructose load, or standardized meal - correlation with the post-prandial BP drop.
4 Recruiting ET50 With Fentanyl for Post Caesarean Section Spinal Hypotension
Conditions: Hypotension;   Pregnancy
Intervention: Drug: Bupivacaine with 15 micrograms of fentanyl
Outcome Measures: Sitting time to avoid Hypotension;   Pain occurence
5 Recruiting Orthostatic Hypotension Among Veterans
Condition: Hypotension, Orthostatic Hypotension
Intervention:
Outcome Measure: Change in blood pressure from supine to standing.
6 Recruiting Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery
Conditions: Endovascular Carotid Surgery;;   Preoperative Hypotension;
Intervention: Drug: ephedrine and phenylephrine
Outcome Measures: Cerebral oxygen saturation (SctO2);   Incidence of post-treatment Hypotension;   Incidence of post-treatment bradycardia;   Postoperative morbidity: cardiovascular, cerebral, renal, surgical;   Postoperative recovery
7 Recruiting Phenylephrine in Spinal Anesthesia in Preeclamptic Patients
Conditions: Preeclampsia;   Hypotension
Interventions: Drug: Ephedrine;   Drug: Phenylephrine
Outcome Measures: The umbilical artery pH in the phenylephrine group will be higher than in the ephedrine group, although the overall incidence of absolute fetal acidosis is not anticipated to be different between groups.;   Efficacy of study drug in preventing and treating Hypotension associated with spinal anesthesia in women with preeclampsia
8 Recruiting Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
Condition: Hypotension
Interventions: Drug: Phenylephrine bolus;   Drug: phenylephrine infusion
Outcome Measures: incidence of nausea and vomiting;   incidence of Hypotension;   neonatal acidosis
9 Recruiting Blood Pressure Guided Biofeedback on Hemodialysis and the Reduction of IntraDialytic Hypotension
Condition: Hypotension
Interventions: Other: BioLogic RR;   Other: Hemodialysis without biofeedback
Outcome Measures: intradialytic Hypotension episodes;   urea clearance;   Brain natriuretic peptide;   intradialytic Hypotension (blood pressure criteria alone);   Intradialytic symptoms
10 Recruiting Treatment of Hypotension of Prematurity (TOHOP)
Condition: Hypotension
Intervention: Other: Anti-hypotensive treatment
Outcome Measures: Neurodevelopmental outcome assessment using the Bayley Scales of Infant Development III;   Incidence of peri-intraventricular haemorrhage;   Incidence of white matter injury and gray matter injury;   Difference in the ability to maintain cerebral blood flow autoregulation;   Mortality
11 Recruiting Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)
Conditions: Parkinson's Disease;   Neurogenic Orthostatic Hypotension in Parkinson's Disease
Interventions: Device: Elastic abdominal binder;   Device: Placebo binder
Outcome Measures: Effect of an elastic abdominal binder versus a placebo binder on mean blood pressure (mmHg) after 3 minutes of orthostatic challenge (on passive tilting) with respect to baseline in Parkinson's disease patients with neurogenic orthostatic Hypotension;   Effect of an elastic abdominal binder versus a placebo binder on systolic blood pressure (mmHg) after 3 minutes of orthostatic challenge with respect to baseline in Parkinson's disease patients with neurogenic orthostatic Hypotension;   Effect of an elastic abdominal binder versus a placebo binder on diastolic blood pressure (mmHg) after 3 minutes of orthostatic challenge with respect to baseline in Parkinson's disease patients with neurogenic orthostatic Hypotension;   Effect of an elastic abdominal binder with respect to a placebo binder on orthostatic symptoms after 3 minutes of orthostatic challenge in Parkinson's disease patients suffering from neurogenic orthostatic Hypotension;   Effect of an elastic abdominal binder with respect to a placebo binder on mean supine blood pressure (mmHg) in Parkinson's disease patients suffering from neurogenic orthostatic Hypotension;   Effects of an abdominal binder on orthostatic symptoms in daily living during 4-weeks open label trial;   Effect of an elastic abdominal binder versus a placebo binder on mean blood pressure (mmHg) after 3 minutes of orthostatic challenge (on active standing) with respect to baseline in Parkinson's disease patients with neurogenic orthostatic Hypotension
12 Recruiting Acarbose and Older Adults With Postprandial Hypotension
Conditions: Other Specified Hypotension;   Syncope
Interventions: Drug: Acarbose;   Drug: Placebo
Outcome Measures: The postprandial cardiovascular response to a standardized meal compared between subjects with and without PPH;   The postprandial glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) response to a standardized meal compared between subjects with and without PPH;   The postprandial cardiovascular response between the Acarbose group and the Placebo group will be compared.
13 Recruiting Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hypotension After Spinal Anesthesia in Parturients
Condition: Hypotension
Intervention: Other: TEAS
Outcome Measures: Incidence of Hypotension;   Average systemic blood pressure(SBP) and diastolic blood pressure(DBP);   Lowest SBP and DBP;   Dosage of ephedrine;   postoperative nausea and vomiting(PONV) score;   Incidence of dizzy and dyspnea;   Change of concentration of serum adrenaline and noradrenaline
14 Not yet recruiting Insulin Therapy and Falls Due to Orthostatic Hypotension
Conditions: Orthostatic Hypotension;   Diabetes;   Syncope
Intervention: Drug: Insulin ( Lantus)
Outcome Measures: 1. Presence or absence of orthostatic Hypotension;   1. The nadir of middle cerebral artery (MCA) velocity;   2. The presence or absence of a positive augmented tilt table test;   3. The nadir of systolic blood pressure (SBP) and diastolic blood pressure (DBP) during tilt table test.
15 Unknown † Fipamezole in Neurogenic Orthostatic Hypotension
Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH);   Parkinson's Disease;   Multiple System Atrophy
Interventions: Drug: Placebo;   Drug: Fipamezole
Outcome Measures: To compare the efficacy of fipamezole with that of placebo on orthostatic Hypotension as assessed by blood pressure response to orthostatism.;   To compare the efficacy of fipamezole with that of placebo on heart rate (HR) response to orthostatism.;   To compare the efficacy of fipamezole with that of placebo on clinical symptoms.;   To explore the relationship between plasma levels of fipamezole and measures of efficacy and safety (pharmacokinetics).;   To assess safety and tolerability of fipamezole.
16 Unknown † Prophylactic Phenylephrine Infusion for Preventing Hypotension During Spinal Anesthesia
Condition: Orthopedic Surgery of Lower Limb
Interventions: Drug: phenylephrine infusion;   Drug: patients receiving saline infusion
Outcome Measures: number of Hypotension episodes;   number of episodes of severe Hypotension;   cardiovascular events;   neurologic events
17 Not yet recruiting Management of Hypotension In the Preterm Infant
Conditions: Hypotension;   Low Blood Pressure;   Intraventricular Hemorrhage of Prematurity
Interventions: Drug: Dopamine hydrochloride;   Drug: Dextrose 5%
Outcome Measures: First Co-Primary Outcome Measure: Survival to 36 weeks postmenstrual age free of severe brain injury;   Second Co-Primary Outcome Measure: Survival without moderate or serious disability as defined using consensus criteria for neurodevelopmental impairment.;   All cause mortality at 36 weeks gestational age
18 Recruiting NOX-100 for Preventing Hypotension During Hemodialysis
Condition: Hypotension
Intervention: Drug: NOX-100
Outcome Measures: Number of Hypotension episode requiring intervention;   systolic blood pressure (SBP);   Onset of symptoms of Hypotension during HD;   The need for treatment intervention to raise BP.
19 Unknown † Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean
Conditions: Preeclampsia;   Pregnancy Toxemias
Interventions: Drug: Metaraminol;   Drug: Ephedrine
Outcome Measures: Incidence of maternal Hypotension;   Maternal and Neonatal outcomes
20 Unknown † Predicting Hypotension During Dialysis in the ICU
Condition: Peridialytic Hypotension
Intervention: Procedure: Transpulmonary Thermodilution
Outcome Measures: hypotensive episode;   fluid removal tolerance;   predicted volume of fluid that can be removed without hypotensive events;   mortality in the ICU;   All cause mortality;   Length of stay in ICU;   Length of stay in hospital